Form 4 for BIIB Biogen
Accepted 2023-03-30 00:00:00 ET · period of report 2023-03-28 · accession 0001127602-23-011661 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-30 | 2023-03-28 | BIIB | Singhal Priya | Head of Development | S - Sale | $270.06 | -568 | 2,842 | -17% | -$153.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-28 | S | D | 568 | $270.06 | 2,842.39 | D | — | — |